Read + Share
Akenroye A, Phipatanakul W. Editorial comment on "Cost-effectiveness of omalizumab for the treatment of
severe pediatric allergic asthma-Results of a real-life study in Spain". Pediatr Allergy Immunol 2023;34:e13980.
PMID: 37492923
|
 |
|
Akenroye A, Phipatanakul W. Editorial comment on "Cost-effectiveness of omalizumab for the treatment of
severe pediatric allergic asthma-Results of a real-life study in Spain". Pediatr Allergy Immunol 2023;34:e13980.
PMID: 37492923
|
|
|
|